Goldman Sachs
ERAS icon

Goldman Sachs’s Erasca ERAS Stock Holding History

Goldman Sachs’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70M Sell
3,822,113
-1,053,073
-22% -$15.1M 0.01% 1518
2026
Q1 		$78.9M Buy
4,875,186
+1,543,768
+46% +$18.2M 0.01% 1212
2025
Q4 		$12.4M Buy
3,331,418
+814,230
+32% +$2.29M ﹤0.01% 2875
2025
Q3 		$5.49M Buy
2,517,188
+697,339
+38% +$1.11M ﹤0.01% 3553
2025
Q2 		$2.31M Sell
1,819,849
-116,408
-6% -$156K ﹤0.01% 4063
2025
Q1 		$2.65M Sell
1,936,257
-865,373
-31% -$1.49M ﹤0.01% 3916
2024
Q4 		$7.03M Sell
2,801,630
-428,726
-13% -$1.18M ﹤0.01% 3118
2024
Q3 		$8.82M Buy
3,230,356
+1,037,720
+47% +$2.92M ﹤0.01% 2847
2024
Q2 		$5.17M Buy
2,192,636
+610,620
+39% +$1.32M ﹤0.01% 3121
2024
Q1 		$3.26M Buy
1,582,016
+284,974
+22% +$570K ﹤0.01% 3475
2023
Q4 		$2.76M Buy
1,297,042
+633,192
+95% +$1.34M ﹤0.01% 3670
2023
Q3 		$1.31M Buy
663,850
+34,348
+5% +$88K ﹤0.01% 4078
2023
Q2 		$1.74M Sell
629,502
-98,897
-14% -$282K ﹤0.01% 3974
2023
Q1 		$2.19M Buy
728,399
+270,294
+59% +$983K ﹤0.01% 3785
2022
Q4 		$1.97M Sell
458,105
-947,512
-67% -$6.42M ﹤0.01% 3955
2022
Q3 		$11M Buy
1,405,617
+964,234
+218% +$7.77M ﹤0.01% 2421
2022
Q2 		$2.46M Buy
441,383
+96,643
+28% +$633K ﹤0.01% 3860
2022
Q1 		$2.96M Buy
344,740
+274,504
+391% +$3.18M ﹤0.01% 3873
2021
Q4 		$1.09M Buy
+70,236
New +$1.2M ﹤0.01% 4766

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Goldman Sachs's ERAS Position: Q2 2026 in Review

Goldman Sachs reduced its Erasca (ERAS) stake by 22% in Q2 2026, selling an estimated $15.1M and leaving 3,822,113 shares worth $70M. The position accounts for 0.01% of the portfolio, ranked #1518.

Goldman Sachs first reported a position in ERAS in Q4 2021 and has held it in 19 quarters since. The position peaked at $78.9M in Q1 2026. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Goldman Sachs held 3,822,113 shares of Erasca worth $70M as of Q2 2026.
  • Goldman Sachs sold 1,053,073 Erasca shares in Q2 2026, an estimated $15.1M.
  • Erasca made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1518 holding.
  • Goldman Sachs first reported a position in Erasca in Q4 2021 and has held it in 19 quarters since.
  • Goldman Sachs's Erasca position peaked at $78.9M in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.